AKT1 and colorectal carcinoma: Next, we treated the CRC cells, HCT116 and SW480, with YYFZBJS at 0, 30, 60, and 90 μg/mL for 24 h and assessed the levels of CDK1 and PI3K/AKT using western blot analysis.